Search research articles
Contact Us
Filters
Showing results (1-10 of 435) with videos related to
Page
of 44
Sort By:
Cardiovascular Drug Reviews
|
October 25, 2002
The low molecular weight heparin, tinzaparin, in thrombosis and beyond
Shaker A Mousa
Medicinal Research Reviews
|
December 25, 2002
alphav Vitronectin receptors in vascular-mediated disorders
Shaker A Mousa
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 5, 2002
Heparin and low molecular weight heparin in thrombosis and beyond
Shaker A Mousa
Journal of Cellular Biochemistry
|
February 22, 2005
Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix-degrading enzyme aggrecanase: structure-function relationship
Shaker A Mousa
Drugs of Today (Barcelona, Spain : 1998)
|
June 28, 2006
Role of current and emerging antithrombotics in thrombosis and cancer
Shaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)
|
July 10, 2010
In vivo models for the evaluation of antithrombotics and thrombolytics
Shaker A Mousa
Timely Topics in Medicine. Cardiovascular Diseases
|
October 27, 2006
Role of current and emerging antithrombotics in thrombosis and cancer
Shaker A Mousa
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 21, 2006
In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography
Shaker A Mousa
Seminars in Thrombosis and Hemostasis
|
July 17, 2007
Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links
Shaker A Mousa
Seminars in Thrombosis and Hemostasis
|
April 16, 2004
Low-molecular-weight heparin in thrombosis and cancer
Shaker A Mousa
Page
of 44
Search research articles
Search
Showing results (1-10 of 435) with videos related to
Sort By:
Page
of 44
Cardiovascular Drug Reviews
|
October 25, 2002
The low molecular weight heparin, tinzaparin, in thrombosis and beyond
Shaker A Mousa
Medicinal Research Reviews
|
December 25, 2002
alphav Vitronectin receptors in vascular-mediated disorders
Shaker A Mousa
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 5, 2002
Heparin and low molecular weight heparin in thrombosis and beyond
Shaker A Mousa
Journal of Cellular Biochemistry
|
February 22, 2005
Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix-degrading enzyme aggrecanase: structure-function relationship
Shaker A Mousa
Drugs of Today (Barcelona, Spain : 1998)
|
June 28, 2006
Role of current and emerging antithrombotics in thrombosis and cancer
Shaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)
|
July 10, 2010
In vivo models for the evaluation of antithrombotics and thrombolytics
Shaker A Mousa
Timely Topics in Medicine. Cardiovascular Diseases
|
October 27, 2006
Role of current and emerging antithrombotics in thrombosis and cancer
Shaker A Mousa
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 21, 2006
In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography
Shaker A Mousa
Seminars in Thrombosis and Hemostasis
|
July 17, 2007
Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links
Shaker A Mousa
Seminars in Thrombosis and Hemostasis
|
April 16, 2004
Low-molecular-weight heparin in thrombosis and cancer
Shaker A Mousa
Page
of 44